Interim analysis of a phase 2 study of lenvatinib (LEN) monotherapy as second-line treatment in unresectable biliary tract cancer (BTC)

被引：3
|
作者：
Morizane, Chigusa
Ueno, Makoto
Sasaki, Takashi
Nagashima, Fumio
Mizuno, Nobumasa
Shimizu, Satoshi
Hayata, Nozomi
Ikezawa, Hiroki
Suzuki, Takuya
Nakajima, Ryo
Dutcus, Corina E.
Ikeda, Masafumi
机构：
[1] Natl Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Tokyo, Japan
[2] Kanagawa Canc Ctr Hosp, Div Hepatobiliary & Pancreat Oncol, Yokohama, Kanagawa, Japan
[3] Canc Inst Hosp JFCR, Tokyo, Japan
[4] Kyorin Univ, Dept Med Oncol, Tokyo, Japan
[5] Aichi Canc Ctr Hosp, Dept Gastroenterol, Nagoya, Aichi, Japan
[6] Saitama Canc Ctr, Dept Gastroenterol, Saitama, Japan
[7] Eisai & Co Ltd, Tokyo, Japan
[8] Eisai Inc, Woodcliff Lake, NJ USA
[9] Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Chiba, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 04期
关键词：
D O I：
10.1200/JCO.2017.35.4_suppl.310
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
310
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: primary analysis results
    Ueno, Makoto
    Ikeda, Masafumi
    Sasaki, Takashi
    Nagashima, Fumio
    Mizuno, Nobumasa
    Shimizu, Satoshi
    Ikezawa, Hiroki
    Hayata, Nozomi
    Nakajima, Ryo
    Morizane, Chigusa
    BMC CANCER, 2020, 20 (01)
  • [2] A phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: Primary analysis results
    Ikeda, M.
    Sasaki, T.
    Morizane, C.
    Mizuno, N.
    Nagashima, F.
    Shimizu, S.
    Hayata, N.
    Ikezawa, H.
    Suzuki, T.
    Nakajima, R.
    Dutcus, C.
    Ueno, M.
    ANNALS OF ONCOLOGY, 2017, 28
  • [3] Phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: primary analysis results
    Makoto Ueno
    Masafumi Ikeda
    Takashi Sasaki
    Fumio Nagashima
    Nobumasa Mizuno
    Satoshi Shimizu
    Hiroki Ikezawa
    Nozomi Hayata
    Ryo Nakajima
    Chigusa Morizane
    BMC Cancer, 20
  • [4] A Phase II Study of Lenvatinib Monotherapy as Second-Line Treatment in Unresectable Biliary Tract Cancer: Primary Analysis Results
    Ikeda, Masafumi
    Sasaki, Takashi
    Morizane, Chigusa
    Mizuno, Nobumasa
    Nagashima, Fumio
    Shimizu, Satoshi
    Hayata, Nozomi
    Ikezawa, Hiroki
    Suzuki, Takuya
    Nakajima, Ryo
    Dutcus, Corina E.
    Bower, John
    Ueno, Makoto
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 115 - 115
  • [5] Phase II study of evofosfamide (TH-302) monotherapy as a second-line treatment in advanced biliary tract cancer
    Yoon, J. S.
    Lee, K-H.
    Cheon, G. J.
    Bang, Y-J.
    Oh, D-Y.
    ANNALS OF ONCOLOGY, 2018, 29
  • [6] A retrospective study for the significance of second-line therapy for unresectable or recurrent biliary tract cancer
    Kawamoto, Yasuyuki
    Komatsu, Yoshito
    Yamamura, Takahiro
    Saito, Rika
    Ito, Ken
    Nakano, Shintaro
    Harada, Kazuaki
    Yuki, Satoshi
    Kuwatani, Masaki
    Sakamoto, Naoya
    ANNALS OF ONCOLOGY, 2021, 32 : S333 - S333
  • [7] A Retrospective Study of S-1 Monotherapy as Second-line Treatment for Patients with Advanced Biliary Tract Cancer
    Kobayashi, Satoshi
    Ueno, Makoto
    Ohkawa, Shinichi
    Andou, Tomoko
    Kameda, Ryo
    Yamamoto, Naoto
    Morinaga, Soichiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 42 (09) : 800 - 806
  • [8] Lenvatinib as second-line treatment in patients with unresectable hepatocellular carcinoma: A retrospective analysis
    Qin, He-nan
    Ning, Zhen
    Sun, Rui
    Jin, Chen-xing
    Guo, Xin
    Wang, A-man
    Liu, Ji-wei
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [9] Nivolumab monotherapy and associations in the treatment of advanced unresectable biliary tract cancer (BTC): A systematic review and meta-analysis
    Filogonio, Victor
    Maia, Yara Rafaela
    Maia, Lucas Henrique
    Beck, Mauren Carbonar
    Beck, Theodoro
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [10] RETROSPECTIVE ANALYSIS OF SECOND-LINE CHEMOTHERAPY IN BILIARY TRACT CANCER
    Lucchesi, Maurizio
    Vasile, Enrico
    Caponi, Sara
    Ginocchi, Laura
    Caparello, Chiara
    Lencioni, Monica
    Ricci, Sergio
    Falcone, Alfredo
    ANNALS OF ONCOLOGY, 2011, 22 : v81 - v81
12345